MedPath

Effects of WB-EMS and Dietetic Treatment on Cancer Patients

Not Applicable
Completed
Conditions
Muscle Loss
Cancer Cachexia
Cancer
Weight Loss
Muscle Weakness
Interventions
Other: Whole-Body Electromyostimulation (WB-EMS)
Registration Number
NCT02293239
Lead Sponsor
University of Erlangen-Nürnberg Medical School
Brief Summary

This study evaluates the effects of a 12-week whole-body electromyostimulation (WB-EMS) training combined with individualized nutritional support on body composition, muscle strength and function and quality of life of patients with malignant disease undergoing curative or palliative anti-cancer treatment

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
278
Inclusion Criteria
  • malignant disease (solid or hematological cancer): head and neck cancer, colorectal carcinoma, small intestinal cancer, gastric cancer, oesophageal cancer, pancreas carcinoma, liver cell carcinoma, cholangiocarcinoma,lung cancer, breast cancer, cervix cancer, ovarian cancer, prostate cancer, renal cell carcinoma, malignant melanoma, patients with leukaemia and malignant lymphomas or Graft-versus-Host-Disease after bone marrow transplantation
  • ongoing or planned curative or palliative anti-cancer therapy
Exclusion Criteria
  • simultaneous participation in other nutritional or exercise intervention trials
  • acute cardiovascular events
  • use of anabolic medications
  • epilepsy
  • severe neurological diseases
  • skin lesions in the area of electrodes
  • energy active metals in body
  • pregnancy
  • acute vein thrombosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
WB-EMS groupWhole-Body Electromyostimulation (WB-EMS)physical exercise group regular WB-EMS training (2 EMS trainings per week; each session for 20 min) + individualized nutritional support (dietary advices: daily protein intake \> 1.0 g/kg bodyweight)
Primary Outcome Measures
NameTimeMethod
Skeletal muscle mass12 weeks

Skeletal muscle mass assessed by bioelectrical impedance analysis (in kg)

Physical function - Gait pattern12 weeks

Sensor-based gait analysis

Secondary Outcome Measures
NameTimeMethod
Patient-reported performance status12 weeks

ECOG performance status/Karnofsky index

Patient-reported Fatigue12 weeks

FACIT-Fatigue scale

Patient-reported Quality of Life (QoL)12 weeks

EORTC QLQ - C30 questionnaire

Physical function - Endurance12 weeks

Six-minute-walk test (walking distance in m)

Physical function - Isometric muscle strength12 weeks

Hand grip strength assessed by hand dynamometer (in kg)

Physical function - Lower limb strength12 weeks

30 second sit-to-stand test (number of sit-to-stand cycles)

Inflammatory blood markers12 weeks

Blood collection and analysis e.g. of C-reactive protein (CRP), Albumin

Trial Locations

Locations (1)

Medizinische Klinik 1, University of Erlangen-Nürnberg

🇩🇪

Erlangen, Bavaria / Franconia, Germany

© Copyright 2025. All Rights Reserved by MedPath